Loading...
| A03701 | Pages: NA | Dec 2021 | 4537 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Biologics And Biosimilars Market
Request Now !Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Moreover, these drugs are approved by FDA due to their similar therapeutical actions as biologics.
The major factors that contribute to the growth of the biologics and biosimilars market include increase in the prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and rise in geriatric population. Moreover, large numbers of clinical trials and innovative R&D approaches to develop advanced drugs drive the market growth. However, manufacturing difficulties due to complexity of drug molecules hinder the market growth. Increase in R&D activities in the field of pharmaceutical industries and rise in therapeutical applications are anticipated to provide new opportunities for the market.
The biologics and biosimilars market is segmented on the basis of type, application, and region. Based on type, the market is divided into antibody, hormone, and growth-factor. By application, it is categorized into tumor, diabetes, cardiovascular, hemophilia, and others. By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 BIOLOGICS AND BIOSIMILARS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ANTIBODY
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. HORMONES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. GROWTH FACTOR
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 BIOLOGICS AND BIOSIMILARS MARKET , BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. TUMOR
5.2.1. Market size and forecast
5.3. DIABETES
5.3.1. Market size and forecast
5.4. CARDIOVASCULAR
5.4.1. Market size and forecast
5.5. HEAMOPHILIA
5.5.1. Market size and forecast
5.6. OTHERS
5.6.1. Market size and forecast
CHAPTER 6 BIOLOGICS AND BIOSIMILARS MARKET , BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Biologics and Biosimilars Market by Type
6.2.5. North America Biologics and Biosimilars Market by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. UK market size and forecast
6.3.3.2. Germany market size and forecast
6.3.3.3. France market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Italy market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Biologics and Biosimilars Market by Type
6.3.5. Europe Biologics and Biosimilars Market by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. China market size and forecast
6.4.3.2. Japan market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Biologics and Biosimilars Market by Type
6.4.5. Asia-Pacific Biologics and Biosimilars Market by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Latin America market size and forecast
6.5.3.2. The Middle East market size and forecast
6.5.3.3. Africa market size and forecast
6.5.4. LAMEA Biologics and Biosimilars Market by Type
6.5.5. LAMEA Biologics and Biosimilars Market by Application
CHAPTER 7 COMPANY PROFILES
7.1. PFIZER INC.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ASTRAZENCA
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. NOVARTIS GLOBAL
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. MERCK & CO. INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. SMITHS MEDICAL
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. GLAXOSMITHKLINE PLC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. CONCORD BIOTECH
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. AUROBINDO PHARMA LTD.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. H.LUNDBECK A/S
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. RETRACTABLE TECHNOLOGIES, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
